Published in Cell Med on April 22, 2014
Novel technology for liver regeneration and replacement. Liver Transpl (2016) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Generation of mouse induced pluripotent stem cells without viral vectors. Science (2008) 15.25
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science (2008) 10.55
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell (2009) 10.52
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29
Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009) 9.29
Immunogenicity of induced pluripotent stem cells. Nature (2011) 7.31
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature (2008) 7.07
Retracted Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature (2014) 6.57
Oct4-induced pluripotency in adult neural stem cells. Cell (2009) 6.50
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology (2010) 6.40
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci (2009) 5.58
Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature (2013) 5.43
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell (2008) 4.52
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
Experience leaves a lasting structural trace in cortical circuits. Nature (2008) 3.66
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol (2011) 3.25
Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell (2008) 3.15
Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One (2009) 3.07
Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA (2008) 3.03
Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res (2009) 2.74
Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation (1999) 2.61
Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells (2009) 2.34
Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology (2010) 2.31
Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res (2008) 2.29
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells (2010) 2.17
Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem (2009) 2.17
DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet (2011) 2.00
Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest (2010) 1.66
In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med (2011) 1.66
Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun (2010) 1.64
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology (2012) 1.64
Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev (2013) 1.63
Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem (2010) 1.59
Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol (2013) 1.49
Mitochondrial rejuvenation after induced pluripotency. PLoS One (2010) 1.46
Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A (2010) 1.44
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44
Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology (2013) 1.34
Developing high-fidelity hepatotoxicity models from pluripotent stem cells. Stem Cells Transl Med (2013) 1.27
High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4. Stem Cells Dev (2012) 1.24
Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development (2013) 1.23
Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum Mol Genet (2011) 1.20
Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28. Genes Cells (2010) 1.19
Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. Int J Biol Sci (2010) 1.14
Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors. Mol Ther (2010) 1.13
Liver regeneration is suppressed in small-for-size liver grafts after transplantation: involvement of c-Jun N-terminal kinase, cyclin D1, and defective energy supply. Transplantation (2006) 1.11
Generation of induced pluripotent stem cells from neural stem cells. Nat Protoc (2009) 1.07
Production of mice using iPS cells and tetraploid complementation. Nat Protoc (2010) 1.01
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies. Stem Cell Res (2012) 1.00
Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Mol Ther (2011) 1.00
Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol Adv (2013) 0.99
Induced pluripotent stem cells: a new era for hepatology. J Hepatol (2010) 0.99
Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. Nat Protoc (2011) 0.99
Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Rev (2013) 0.98
In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance. Cancer Res (2011) 0.98
Regeneration-induced accelerated rejection in reduced-size liver grafts. Transplantation (1994) 0.95
Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration. Mol Ther (2007) 0.93
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. Biochem Biophys Res Commun (2011) 0.93
Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle (2011) 0.93
Distinct intragraft response pattern in relation to graft size in liver transplantation. Transplantation (2003) 0.92
Exploring refined conditions for reprogramming cells by recombinant Oct4 protein. Int J Dev Biol (2010) 0.91
Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med (2011) 0.91
An in vitro expansion system for generation of human iPS cell-derived hepatic progenitor-like cells exhibiting a bipotent differentiation potential. PLoS One (2013) 0.91
Application of whole-organ tissue engineering in hepatology. Nat Rev Gastroenterol Hepatol (2012) 0.89
Efficient derivation of functional hepatocytes from mouse induced pluripotent stem cells by a combination of cytokines and sodium butyrate. Chin Med J (Engl) (2011) 0.88
Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute? J Hepatol (2003) 0.86
Auxiliary partial liver grafting in rats: effect of host hepatectomy on graft regeneration, and review of literature on surgical technique. Microsurgery (2002) 0.86
Generation of human induced pluripotent stem cells from cord blood cells. J Stem Cells (2011) 0.85
An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cells. Hepatology (2010) 0.85
Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy. Protein Cell (2012) 0.85
Establishment of a highly differentiated immortalized adult human hepatocyte cell line by retroviral gene transfer. Transplant Proc (2000) 0.84
Cellular loss after allogenic hepatocyte transplantation. Transplantation (2009) 0.82
Could co-transplantation of iPS cells derived hepatocytes and MSCs cure end-stage liver disease? Cell Biol Int (2009) 0.81
Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Arch Pharm Res (2012) 0.80
Stem cells and hepatic cirrhosis. Panminerva Med (2010) 0.79
Using human-induced pluripotent stem cells to model monogenic metabolic disorders of the liver. Semin Liver Dis (2013) 0.78
Stem cells as a novel tool for drug screening and treatment of degenerative diseases. Curr Pharm Des (2012) 0.78
Improved hepatic regeneration with reduced injury by redox factor-1 in a rat small-sized liver transplant model. Am J Transplant (2004) 0.76
Aging in the mouse and perspectives of rejuvenation through induced pluripotent stem cells (iPSCs). Results Probl Cell Differ (2012) 0.75